000 01370 a2200373 4500
005 20250517111537.0
264 0 _c20170616
008 201706s 0 0 eng d
022 _a1532-2777
024 7 _a10.1016/j.mehy.2016.07.001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLawrence, James R
245 0 0 _aAspirin for cancer is no mere antiplatelet prototype. There is potential in its ancient roots.
_h[electronic resource]
260 _bMedical hypotheses
_cSep 2016
300 _a74-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAspirin
_xadministration & dosage
650 0 4 _aBlood Platelets
_xdrug effects
650 0 4 _aColorectal Neoplasms
_xprevention & control
650 0 4 _aCyclooxygenase Inhibitors
_xchemistry
650 0 4 _aGastrointestinal Diseases
_xchemically induced
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xprevention & control
650 0 4 _aPlatelet Aggregation Inhibitors
_xadministration & dosage
650 0 4 _aPreventive Medicine
650 0 4 _aRisk
650 0 4 _aSalicylic Acid
_xchemistry
650 0 4 _aVascular Diseases
_xdrug therapy
700 1 _aBaxter, Gwendoline J
700 1 _aPaterson, John R
773 0 _tMedical hypotheses
_gvol. 94
_gp. 74-6
856 4 0 _uhttps://doi.org/10.1016/j.mehy.2016.07.001
_zAvailable from publisher's website
999 _c26319496
_d26319496